Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-01-27
1993-11-16
Ellis, Joan
Drug, bio-affecting and body treating compositions
Lymphokine
435 693, 4351723, 4352351, 4353201, 4352523, 43525233, 4352402, 536 235, 530350, 835 9, 835 32, 835 41, 835 57, 835 65, 835 70, 835 73, A61K 3912, C12P 2102, C12P 1934, C12N 1500, C12N 700, C12N 500, C12N 121, C12N 116
Patent
active
052621774
ABSTRACT:
Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4719177 (1988-12-01), Baltimore et al.
Brown et al., J. of Immunology, vol. 127, pp. 538-546 (1981).
Additional pages of Maniaks et al., Moleculer Cloning: A Laboratory Manual, pp. 224-228, 270-274, 350-352.
Lehninger Biochemistry 2nd Edition Worth Publishers Inc., New York, NY (1975) pp. 125-152.
Korman et al., Proc. Natl. Acad. Sciences 00179 pp. 1844-1848 (1982).
Okayama et al., Mol. Cell. Bio. vol. 2, pp. 161-170 (1982).
Helfman, D. M. et al., Proc. Natl. Acad. Sci. USA vol. 80 pp. 31-35 (1983).
Suggs et al. Proc. Nat'l. Acad Sci. USA vol. 78, pp. 6613-6617 (1981).
Maniatis et al., Molecular Cloning, A Laboratory Manual, Cold Spray Harbor Laboratory, CSH, NY (1982) pp. 404-435.
Berkner, K. L. et al., Nucl. Acids. Res. vol. 12 pp. 1925-1941 (1984).
Brown, J. P., Nature vol. 296 pp. 171-173 (1982).
Brown et al., 1980, J. Biol. Chem. 255:4980-4983 (Brown III).
Dippold et al., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:6114-6118.
Woodbury et al., 1980, Proc. Natl. Acad. Sci. U.S.A., 77(4):2183-2187 (Woodbury I).
Brown et al., 1981, J. Immunol. 127:539-547 (Brown II).
Woodbury et al., 1981, Int. J. Cancer 27:145-149 (Woodbury II).
Brown et al., 1981, Proc. Natl. Acad. Sci. U.S.A. 78(1):539-543 (Brown IV).
Garrigues et al., 1982, Int. J. Cancer 29:511-515.
Plowman et al., 1983, Nature 303:70-72.
Larson et al., 1983, J. Clin. Invest. 72:2101-2114.
Khosravi et al., 1985, Int. J. Cancer 35:73-80.
Shiku et al., 1876, J. Exptal. Med. 144:873-881.
Bystryn, 1978, J. Immunol. 120:96-101.
Yang et al., 1984, Proc. Natl. Acad. Sci. U.S.A. 81:2752-2756.
Metz-Boutique et al., 1984, Eur. J. Biochem. 145:657-679.
Hellstrom et al., 1968, Nature 220:1352-1354 (Hellstrom I).
Hellstrom et al., 1970, Int. J. Cancer 6:346-351 (Hellstrom II).
Hoover et al., 1985, Cancer 55:1236-1243.
Hopp & Woods, 1981, Proc. Natl. Acad. Sci. U.S.A. 78:3824-3828.
Young & Davis, 1983, Proc. Natl. Acad. Sci. U.S.A. 80:1194-1195.
Cochran et al., Eucaryotic Transient Expression System Dependent on Transcription Factors and Regulatory DNA Sequences of Vaccinia Virus, 1985, Proc. Natl. Acad. Sci. U.S.A. 82:19-23.
Haj-Amad and Graham, 1986, Development of a Helper-Independent Human Adenovirus Vector and Its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene, J. Virol. 57:267-276.
Mansour et al., An Adenovirus Vector System Used to Express Polyoma Virus Tumor Antigens, 1985, Proc. Natl. Acad. Sci. U.S.A. 82:1359-1363.
Subramani and Southern, 1983, Analysis of Gene Expression Using Simian Virus 40 Vectors, Anal. Biochem. 135:1-15.
Kaufman and Sharp, 1982, Amplification and Expression of Sequences Cotransfected With a Modular Dihydrofolate Reductase Complementary DNA, Gene, J. Mol., Biol. 159:601-621.
Kuroda et al., Expression of the Influenza Virus Haemagglutin in Insect Cells by a Baculovirus Vector, 1986, EMBO J. 5:1359-1365.
Maeda et al., Production of Human a-Interferon in Silkworm Using a Baculovirus Vector, 1985, Nature (London), 315:592-594.
Kramer et al., HTLV-III gag protein Is Processed In Yeast Cells By The Virus Pol-Polymerase, 1986, Science 231:1580-1584.
Valenzuela et al., Synthesis and Assembly of Hepatitis B Virus Surface Antigen Particles in Yeast, 1982, Nature (London) 298:347.
Yanisch-Perron et al., 1985, Improved M13 Phage Cloning Vectors and Host Strains: Nucleotide Sequences of the M13mp18 and pUC19 Vectors, Gene 33:103-119.
Young and Davis, Efficient Isolation of Genes Using Antibody Probes, 1983, Proc. Natl. Acad. Sci. U.S.A. 80:1194-1198.
Dunn and Studier, Complete Nucleotide Sequence of Bacteriophage T7 DNA and the Locations of T7 Genetic Elements, 1983, J. Mol. Biol. 166:477-536.
Palmiter et al., 1983, Metallothionein-Human GH Fusion Genes Stimulate Growth of Mice, Science 222:809-814.
Taub and Thompson, 1982, an Improved Method for Preparing Large Arrays of Bacterial Colonies Containing Plasmids for Hybridization: In Situ Purification and Stable Binding of DNA on Paper Filters, Anal. Biochem. 126:222-230.
Backman and Boyer, 1983, Tetracycline Resistance Determined by pBR322 Is Mediated By Onbe Polypeptide, Gene 26:197-203.
Brown Joseph P.
Estin Charles D.
Hellstrom Ingegerd
Hellstrom Karl E.
Hu Shiu-Lok
Ellis Joan
Oncogen
LandOfFree
Recombinant viruses encoding the human melanoma-associated antig does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant viruses encoding the human melanoma-associated antig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant viruses encoding the human melanoma-associated antig will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-20874